GST Impact: NPPA Announces Ceiling Price For 761 Medicines


Country’s drug price regulator, National Pharmaceutical Pricing Authority (NPPA) on Tuesday announced provisional ceiling prices for 761 medicines, including HIV, diabetes, anti-cancer and antibiotic. Prices for a majority of drug are being reduced as the GST regime is nearing its implementation deadline of July 1.

According to NPPA Chairman Bhupendra Singh, the actual increase or decrease in drug prices post-GST is expected to be in the range of 2-3% depending on states.

NPPA has asked pharma companies to intimate corrections by June 29.

The ceiling price of HIV combination drug of Tenofovir (300mg), Lamivudine (300mg) and Efavirenz (600mg) has been fixed at Rs 89.69 per tablet, down from Rs 93.52 per tablet. Price of one tablet of HIV treatment drug Darunavir has been fixed at Rs 151.4, down from Rs 157.93. Besides, cost of one tablet of Lamivudine and Zidovudine combination has been reduced to Rs 18.20 from Rs 18.98 currently, reported a leading news agency.

While, the price of one tablet of Entecavir, used in the treatment of Hepatitis B, has dropped to Rs 69.44 from Rs 72.40.

For Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔


Share on Google Plus

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments: